How Can Hiv Treatment Costs Be Reduced
Using generic instead of branded drugs can dramatically reduce HIV treatment costs. In 2016, a new programme to encourage clinicians to switch patients to generic antiretroviral drugs saved the NHS almost £10 million in one year. Two-thirds of the savings came from patients switching to generic medication and a third from renegotiating contracts with pharmaceutical companies, who were under pressure to lower prices. A Public Health England study in 2019 found that if doctors continue to switch patients to generic drugs as soon as they become available, they could save the NHS as much as £7 billion by 2033.
In the UK, generic treatments for HIV are widely used. However, switching to generic medications should only be done if clinically appropriate, and in some cases the most effective treatments are only available in branded versions. Some people may also experience greater side-effects or other problems with a generic treatment. Consequently, reducing the prices of branded drugs is also important for making savings on HIV treatment. In part, this can be achieved through greater transparency around price-setting and the costs of research, development, and production of HIV treatment.
*Converted from US Dollars using 2019 average exchange rate .**Converted from US Dollars using 2018 average exchange rate .
Visit Drug Pricing Websites
Drug pricing websites such as GoodRx.com have information on the average costs for medications at several different major pharmacies and offer coupons for further savings. In addition, the site describes how a medications cost has averaged over time and how it compares to the cost of other similar medications.
Hiv Drugs Cost $75 In Africa $39000 In The Us Does It Matter
In the United States, pharmaceutical companies have built a system which supports high costs for H.I.V. drugs. But that may be starting to change.
Ms. Rosenberg is a co-founder of the Solutions Journalism Network, which supports rigorous reporting about responses to social problems.
First of two articles
A new gold-standard triple therapy for H.I.V. has just made its debut in Africa. It costs $75 a year. In the United States, many people with H.I.V. take an almost identical therapy. It costs $39,000 a year.
The United States is infamous for its high cost of health care and H.I.V. medicines are a big part of that. Plenty of drugs carry outrageous prices: EpiPens, insulin, cancer treatments, even some antibiotics. But no class of medicines is more scandalously expensive than for H.I.V. These medicines are in Medicaids drug budget, the third largest for the insurance exchanges and the fifth largest for commercial insurers.
What do we get from spending so much? Not enough. H.I.V. therapy aims to suppress the virus to the point where it is undetectable in a patients blood. Patients with suppressed H.I.V. are healthy and noncontagious. Just under half of all people living with H.I.V. in the United States have achieved that. Thats not only way below countries like Britain and France; its worse than Zimbabwe, Kenya and Malawi.
Mylan also makes three-drug combos, Symfi and lower-dose Symfi Lo. At 40 percent less, the two Symfi combinations cost $19,200.
No one has.
You May Like: How I Found Out I Had Hiv
What Is The Global Status Of Hiv Treatment Uptake
The number of people living with HIV receiving antiretroviral treatment has climbed dramatically in the past ten years. In 2019, 25.4 million people were on ART, more than triple the number of people in 2010. However, because the level of HIV testing among people who are HIV positive is not yet high enough, this equates to 67% of all people living with HIV.18.
Progress on expanding treatment is uneven. Certain regions continue to lag behind including West and Central Africa , eastern Europe and central Asia and the Middle East and North Africa .19.;
Furthermore, across different global regions, men are less likely than to receive treatment. In 2017, only 53% of HIV positive men compared to 65% of HIV positive women were accessing ART. Disparities between treatment coverage among men and women were greatest in West and Central Africa. For example, in Togo only 39% of HIV positive men had access to ART compared to 72% of their female counterparts.20
Children and are all also often underserved. In 2017, only 941,000 children had treatment access, equivalent to just over half of all HIV positive children . As a result of poor treatment access, 110,000 children died from AIDS-related illnesses that year.21
Treatment And Care: Learning To Live With Hiv
The methods for treating and caring for individuals with HIV went through a revolution in the 21st century. Here are some things newly diagnosed individuals should know:
Who provides HIV care?
HIV care can be provided by an infectious disease specialist, but internal medicine specialists, general practice doctors and nurse practitioners can all potentially be the primary physician someone with HIV goes to. Preventing HIV from developing into AIDS, though, is not a matter of just sticking to a drug regimen â and healthcare providers approach it holistically. For instance, people living with HIV may need to see a nutritionist regularly to make sure their diet is appropriate. Similarly, appointments with a mental health counselor or substance abuse counselor may also be essential in maintaining â or transitioning to â wellness.
When should I start looking for an HIV provider?
Find an HIV provider as soon as you are diagnosed so you can get on ARVs quickly and begin slowing the virus. Local nonprofits can help you find providers in your area, as can clinics that provide testing services. Family doctors can also recommend and refer you to quality providers.
How can I prepare for my first appointment? How can I get the most out of my care?
You May Like: Does Hiv Cause Hair Loss
The Situation In Nigeria
In Adamawa state, which has a population of 3.1 million people, there is an HIV prevalence of 3.8%. In Akwa Ibom, where 3.9 million people live, there is a prevalence rate of 10.9% and in Anambra state there is a prevalence rate of 8.7% for a population of 4.1 million people.
At all the sites that formed part of our study, antiretroviral therapy was fully subsidised by the government and development partners.
In Anambra state, treatment for opportunistic infections was fully subsidised. In Adamawa, some facilities received fully subsidised treatment for opportunistic infections. But in Akwa Ibom, all patients were routinely charged a fee for treating such infections. In all cases, patients were still expected to pay for their laboratory tests and other incidental expenditures on co-morbidity.
We found that in Anambra, where the treatment for opportunistic infections was subsidised, close to 80% of the respondents were treated for opportunistic infections. But in Akwa Ibom, where patients were charged, only 25% accessed such treatment. In Adamawa, where only some opportunistic infection treatments were subsidised, 45% accessed treatment.
Cost Sharing In The United States
Prescription drug pricing in the United States involves complex systems with varying requirements for mandatory and voluntary discounts, rebates, and reimbursement rates, and much of the pricing information is confidential. Prices can vary depending on the state, purchaser, type of public or private insurance coverage in use, and number of generic competitors to branded drugs . Therefore, providers may find it difficult to navigate payer cost-containment practices, including formulary restrictions, prior authorization requirements, and patient cost-sharing arrangements, such as copayments , coinsurance , and insurance deductible payments.
Maximum allowable copayments on prescription drugs covered by Medicaid can vary by family income, but they are usually nominal. For commercial insurers, cost sharing generally is subject to maximum payment rules under the Affordable Care Act . Manufacturer cost-sharing assistance programs are available for most brand-name ARV products but may be restricted by pharmacy and by state. Manufacturer copay assistance also may be subject to copay accumulator programs implemented by insurers pharmacy benefit managers , whereby manufacturer payments do not count toward a patients deductible or out-of-pocket maximum.;
Other Expenses To Consider
In some cases, treatment and medication costs are just part of the equation. For some, particularly low-income people, even smaller expenses can be overwhelming. Some costs to keep in mind include:
Many health centers and clinics across the U.S. offer free HIV testing – to find a location, visit the CDC’s GetTested website. If you prefer to use an FDA-approved home test, however, you’ll need to pay for that out-of-pocket. Common tests include:
|Rapid antibody screening||The most efficient test, rapid antibody screening produces results within half an hour.||A recent study found the average cost to be $8 to $60, but the cost can be even less – HIV tests are now required to be covered by insurers without a copay under the ACA.|
|OraQuick In-Home HIV test||This FDA-approved home testing method involves using an oral swab to gather a saliva sample. The results are ready within 20 minutes. The manufacturer will give you confidential counseling and refer you to treatment.||Between $40 to $45 and is sold at OraQuick.com and authorized national retailers.|
|Home Access HIV-1 test||Available for home use, this method requires you to submit a blood sample from a finger prick. You then mail the sample to a licensed laboratory and receive results within one to two business days. The test is anonymous, and the manufacturer will give you confidential counseling and refer you to treatment.||Between $40 and $60 and is sold online and in most major drugstores.|
The Domestic Hiv Budget
The domestic HIV budget includes funding for care, cash/housing assistance, prevention, research, and the Minority HIV/AIDS Initiative as follows:
The largest component of the federal HIV budget is health care services and treatment for people living with HIV in the U.S., which totaled $21.5 billion in FY 2019 . This represents a 5% increase over the FY 2018 level, primarily due to increased mandatory spending for Medicaid and Medicare.2 Medicare is the largest federal funder of HIV care and treatment, followed by Medicaid. The Ryan White HIV/AIDS Program, the largest HIV-specific discretionary grant program in the U.S. and third largest source of federal funding for HIV care , is funded at $2.3 billion, the same as the FY18 level. Ryan Whiteâs AIDS Drug Assistance Program , which provides access to HIV-related medications to people with HIV, was flat funded at $900.3 million.
$3.1 billion of the FY 2019 budget for HIV is for cash and housing assistance in the U.S. , a slight increase over the FY 2018 level. This includes mandatory spending estimates for SSI and SSDI, which provide cash assistance to disabled individuals with HIV. Housing assistance, through the Housing Opportunities for Persons with AIDS Program , is discretionary and received $393 million in FY 2019, an $18 million increase over the FY 2018 level.
Minority HIV/AIDS Initiative
Read Also: How Long Do Hiv Results Take
The Cost Of Hiv Treatment
Forty years ago, HIV and AIDS were unheard of in the United States. The first cases of what was then a mysterious illness were diagnosed in the 1980s, but effective treatments took several more decades to develop.
A cure for HIV doesnt yet exist, but treatments are available to extend the lives of those with HIV and help stop transmission of the virus. Many of the highly active antiretroviral therapies available today work effectively to slow the progression of disease caused by HIV.
But all treatments come with a cost some more than others. Lets take a look at the average costs of HIV treatment and potential ways to save money.
Text Version Of Figure 47
- Cumulative NSP expend: this slowly increases from about $0 in 1991 to about $1 million in 2002.
- Cumulative HIV costs avoided: this slowly increases from about $0 in 1991 to about $2 million in 2002, and then increases more steadily to about $6 billion in 2030. The costs avoided then increases more slowly to about $7 billion in 2054, before remaining steady at about $7 billion for subsequent years.
Also Check: What Is Hiv 1 And 2 Antibody Test
Funding For The Ending The Hiv Epidemic Initiative
For information about FY2021 HHS budget resources supporting the implementation of the Ending the HIV Epidemic initiative, as well as FY2020 and FY2019 budget allocations, see Ending the HIV Epidemic Funding
Each year, the U.S. government spends billions of dollars to help people in the United States and countries around the world who are living with or at risk for HIV.
By law, federal programs must provide information on how they spend the funds they receive. Transparency in government promotes accountability, and provides meaningful access to information so that citizens can know what their government is doing and how federal dollars are being spent. Review the chart below for an overview of federal budget allocations for domestic HIV programs and research in FY2020 and FY2021. For information about federal resources supporting the Ending the HIV Epidemic initiative, see;Ending the HIV Epidemic Funding.
The Economic Cost Of Hiv/aids In Canada
13 April, 2011
This report was undertaken to provide an updated estimate of costs related to HIV/AIDS in Canada, with a particular focus on the costs of treatment and costs associated with loss of productivity for lost work hours. It is a follow-up document to the 2001 study The Cost of HIV/AIDS in Canada by Colin Dodds, MA, Ronald Colman, PhD, Carol Amaratunga, PhD, and Jeff Wilson, BES, GPI Atlantic.
The Canadian AIDS Society gratefully acknowledges Rx&D: Canadas Research-Based Pharmaceutical Companies for their support and funding for the development and production of this paper, as well for their ongoing support to people living with HIV/AIDS.
Read Also: How Much To Get Hiv Test
How Much Does Treatment Cost
Treatment for HIV is available throughout Australia at highly subsidised costs for holders of Australian Medicare Cards, through the Pharmaceutical Benefits Scheme which is a scheme of the Australian Government which is said to create affordable medicines for all Australians, for their health-care needs.
Patients make a small co-payment for each item listed on their prescription.
From 1 January 2017, you pay up to $38.80 for most PBS medicines or $6.30 if you have a concession card. The Australian Government pays the remaining cost.
The amount of co-payment is adjusted on 1 January each year in line with the Consumer Price Index .
A Safety Net also applies for Individuals and families, which reduces the annual cost of medicines when co-payments reach a certain threshold.; For more information on the PBS visit their website. Specific costs and Safety Net Thresholds can be found here.
The PBS covers all health conditions for medicines which are approved in Australia and listed on the PBS.; All highly specialised HIV anti-retroviral drugs are listed on the PBS, along with other general medicines for other health conditions as well.
HIV treatment usually comprises of a three drug combination of pills.; These can be prescribed by your doctor as either 3 separate pills, or 3 drugs combined into one single pill, or sometimes 2 drugs in one single pill plus another pill depending upon your particular prescribing needs as recommended by your doctor.
Why Is Hiv Treatment So Expensive
Around two-thirds of the lifetime cost of managing HIV in the UK relates to the cost of antiretroviral drugs, with £429 million spent on anti-HIV drugs in 2015-2016. Prices of drugs vary depending on whether they are branded or generic, and the discounts that the NHS can negotiate with pharmaceutical companies.
Branded drugs are typically far more expensive than generic drugs because the pharmaceutical company that owns the drugs patent has a monopoly on its production. When a drugs patent expires, other companies are allowed to manufacture and sell the drug. If multiple companies are competing against each other, this drives prices down. Generic prices are usually around 80% lower than the prices paid for branded drugs.
Price discount agreements are often confidential, but an anonymised study found that they are generally 20-30% lower than the list price of a drug. However, list prices can vary dramatically from country to country, even for the same drug.
As a result of a global campaign in the 1990s to improve access to HIV treatment, low-income countries typically have licensing agreements with pharmaceutical companies which mean they can access HIV drugs at much lower prices. Pharmaceutical companies then charge higher prices to high-income countries to offset this discount.
The presence of one or more additional health conditions at the same time as a primary condition .
Also Check: Is Pep Effective In Preventing Hiv
Make Best Use Of Adap Benefits
The;AIDS Drug Assistance Program ;has long been considered the first-line resource for HIV medications for low- to middle -income Americans. Since its inception in 1987,;the scope of the program has expanded considerably, with some states now integrating medical care, lab tests, insurance assistance, and even;HIV preventive therapy;into their benefits schedule.
As with other federally funded programs, eligibility is based largely on income, the thresholds of which can vary considerably from state to state. Proof of residency and documentation of HIV status are required.
While most states will limit eligibility to U.S. citizens and documented residents only, some like Massachusetts, New York, and New Mexico have now extended ADAP assistance to undocumented immigrants, as well.
Meanwhile, six U.S. states restrict benefits to individuals or families whose personal net assets fall beneath a specific threshold, ranging from less than $25,000 in New York State to less than $4,500 in Georgia.
The current ADAP income eligibility thresholds are outlined as follows:
ADAP is typically considered a payer of last resort, meaning that, unless you qualify for Medicaid or Medicare, you will need to enroll in some form of private or employer-based insurance.